Cannabis Law Report

DECEMBER 17, 2021

Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome patient pool and forecasted trend for each seven major countries. DUBLIN–(BUSINESS WIRE)–The “22q11.2 Country-Wise Epidemiology. Key Findings.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Veriheal

APRIL 23, 2024

Cannabis use is increasing all around the world. The American marijuana industry was worth about $57 billion in 2023 and is projected to reach $444 billion by 2030, a staggering growth that reflects it as the fastest-growing industry anywhere in the world.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Cannabis Law Report

FEBRUARY 3, 2022

DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global cannabis market in the COVID-19 period has been estimated to value USD 25,650.4 million by 2030 at a CAGR of 23.9%, 2021-2030.

Indica 52

Indica Oil Legalization Research and Development 52

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 109

Cultivation Data DEA Dispensary 109

Cannabis Law Report

JUNE 7, 2021

The Phase 1 clinical trial on Alzheimer’s patients is currently anticipated to conclude during the July through September 2021 timeframe. According to World Health Organization, Alzheimer’s disease is expected to impact approximately 50 million individuals worldwide by 2030.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Cannabis Law Report

AUGUST 3, 2021

Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. But, of course, the growth in the market will depend mainly on accurately diagnosing patients with certain mental illnesses and successfully treating those conditions with psychedelics. Medxtractor Corp.

Research and Development 105

Research and Development Data Conditions Therapy 105

MGC Pharma

FEBRUARY 22, 2018

According to the Australian Bureau of Statistics, the number of people aged 65 years or older is expected to exceed the number of children aged 14 and below by as soon as 2030. A recent Hawaii-based study of 2,736 patients above the age of 65 found that, after six months, 93.7%

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100